ArticleJBMR plus2026
Knowledge, skills, and attitudinal gaps in fibrodysplasia ossificans progressiva diagnosis and management in the United States.
Article in JBMR plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare and disabling disease. Preventing unnecessary and/or harmful medical procedures to patients requires early and accurate diagnosis, multidisciplinary care, and access to specialists with FOP expertise. This study aims to assess the needs of healthcare providers (HCPs) when providing care to patients with FOP. Knowledge, confidence, and management practices were measured through a short awareness survey, completed by 400 HCPs from different specialties who may encounter patients with FOP. Complementary qualitative data were obtained from a dialogue session about FOP. Quantitative data was analyzed using descriptive and inferential analysis, while qualitative data underwent thematic coding. Results indicate a need for enhanced knowledge and confidence regarding identifying clinical manifestations of FOP, referral to FOP specialists and subsequent patient management. Only 8.8% of HCPs correctly identified FOP from an open-ended question showing malformed great toes, a classical clinical manifestation of FOP, and only 31.8% correctly identified FOP from a multiple-choice question showing heterotopic ossification on a child's back, another classical clinical manifestation of FOP. Structural and system-level issues were also identified as barriers to optimal patient care pathways, with limited access to FOP specialists reported as a prominent concern. These results document a need for improvements in HCP knowledge in addition to local care collaboration and healthcare system optimization to meet the needs of patients with rare diseases. Given that FOP is an ultra-rare disease, educational interventions are recommended to focus on rare disease recognition, with FOP included as one topic. In addition, greater team collaboration and system-level approaches to assist HCPs in overcoming barriers that impede patient access to care and ongoing management, as well as interventions to enhance patients' capacity to have informed communication with their HCPs, are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.